The ALPP Knockout 769-P Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human 769-P renal cell carcinoma line, engineered to disrupt the ALPP gene encoding placental alkaline phosphatase. This loss-of-function model leverages CRISPR/Cas9-mediated gene disruption to abolish ALPP expression, providing a robust tool for investigating the enzyme’s roles in phosphate metabolism, folate biosynthesis, and tumor microenvironment signaling. The polyclonal format offers a heterogeneous population of edited cells, suitable for assays that do not require clonal isolation.
The 769-P host cell line is an epithelial model established from a primary clear cell renal cell carcinoma, widely utilized in kidney cancer research. These cells retain characteristics of their tumor origin, including key signaling pathway alterations, making them a relevant system for studying oncogenic mechanisms, drug responses, and metastasis. Their human origin ensures translational relevance for preclinical investigations.
ALPP encodes a glycosylphosphatidylinositol (GPI)-anchored membrane enzyme that hydrolyzes phosphate monoesters at alkaline pH, with essential roles in phosphate metabolism and folate absorption. The enzyme requires zinc and magnesium ions as cofactors and interacts with caveolin-1 for proper membrane localization. ALPP transcription is regulated by SP1 and AP-2 transcription factors, beta-catenin/TCF signaling, and retinoic acid, integrating developmental and oncogenic cues. Downstream, ALPP mediates dephosphorylation of extracellular nucleotides and cell surface proteins, generating inorganic phosphate and modulating the tumor microenvironment, which can influence processes such as cell migration and invasion.
In the context of 769-P cells, ALPP knockout enables dissection of placental alkaline phosphatase function within a renal epithelial carcinoma model. Although ALPP is primarily associated with germ cell tumors, its aberrant expression in renal cell carcinoma may contribute to phosphate dysregulation and microenvironment remodeling. Disruption of ALPP in this background allows researchers to isolate its contributions to phosphate handling, signal transduction, and potential crosstalk with renal cancer pathways, offering insights into tumor progression mechanisms.
This knockout model supports diverse experimental applications, including phosphatase activity profiling using colorimetric assays with p-nitrophenyl phosphate (pNPP) substrate, Western blotting, and immunofluorescence for validation. It is well-suited for cell proliferation, migration, and invasion assays to assess metastatic potential, as well as drug sensitivity screens to evaluate resistance mechanisms. Transcriptomic studies via RNA-seq can further map ALPP-dependent gene networks. For additional information or technical support, please contact Ascent Research.
